65,437 trials
Anesthetic Effectiveness
Primary: Successful Pulpal Anesthesia. — 37; 27; 22; 33 participants
Stress Urinary Incontinence · Cell Therapy
Primary: Number of Participants That Experienced Biopsy Procedure-related Adverse Events — 3 participants
Other Acute Pain · Chronic Pain
Primary: Pain Status Change for Sacroiliac Joint Pain Intensity — -2.4; -0.8 units on a scale — p=0.035
Heart Failure
Primary: Death, Heart Transplant, Left Ventricular Assist Device Implantation — 35 participants
Surgical Procedures, Elective
Primary: Incidence of Residual Neuromuscular Blockade (NMB) as Defined by a Train-of-Four (TOF) Ratio <0.9 at Post Anesthesia Care Unit (PACU) Entry — 0; 33 participants…
Aortic Aneurysm
Primary: All-cause Mortality — 146; 146 participants — p=0.81
Congestive Heart Failure · Diabetes Mellitus
Primary: Hospital Length of Stay — 7; 8 days
Cocaine Dependence
Primary: Cocaine Use Over the Eight Week Trial as Measured by Twice Weekly Urine Drug Screen — 1.3; 1.2 cocaine abstinent weeks — p=0.44
Asthma
Primary: Forced Expiratory Volume (FEV1) Peak (0-3h) Response — 0.185; 0.261; 0.290; 0.272 Litre — p=0.0002
Anesthesia
Primary: Heart Rate and Blood Pressure Double Product — 9114; 8804 (beats/minute)*mmHg
Melasma
Primary: Number of Participants Showing Improvement of Melasma Based on Mexameter Readings — 18 participants
Temporomandibular Disorders
Primary: Pain Intensity (German Pain Questionnaire; Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD)) — 5.40; 5.53; 3.90; 3.89 units on a scale
Coronary Artery Stenosis
Primary: Impact on the Trajectory of Serum and Urinary Neutrophil Gelatinase-associated Lipocalin (NGAL) Following Administration — -27.76; -11.11; -11.84; -8.23 ng/mL
Malignant Melanoma
Primary: SciBase Sensitivity and Specificity — 96.6; 31.4 Percentage of total lesions — p=<0.0001
Post-menopausal Osteoporosis
Primary: Percentage Change in Total Hip Bone Mineral Density BMD at Year 6 (Baseline) and Year 9 — -0.54; -1.31 Percentage Change of BMD